South and Central America Colonoscopes Market Drivers and Forecasts by 2028

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

South and Central America Colonoscopes Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Fiber Optic Colonoscopy Devices and Video Colonoscopy Devices), Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, and Polyp), and End User (Hospitals, Ambulatory Surgery Center, and Others)

  • Report Date : Nov 2021
  • Report Code : TIPRE00025867
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 123
Page Updated: Nov 2021

The South and Central America colonoscopes market is expected to reach US$ 169.50 million by 2028 from US$ 136.89 million in 2021; it is estimated to grow at a CAGR of 3.5% from 2021 to 2028. A few factors such as the increasing prevalence of colorectal cancer, growing research activities to extend its applications in therapeutic areas, technological advancements in colonoscopy devices, and development of robotic colonoscopes are driving the growth of the colonoscopes market. However, the availability of alternative diagnostic tests for rectal diseases hampers the market growth.

Colorectal cancer is a malignant tumor that develops in the tissues of colon or rectum. Colon and rectal cancer are often grouped due to common features of both conditions. According to an article published online by science direct, in 2016, colorectal cancer is one the 5 the leading cancer diagnosis in Central and South America and males have 1–2 times higher colorectal cancer rates than females. Furthermore, it is the second leading cause of cancer death in the country, among men and women combined, while it stands as the third leading cause of cancer death when men and women are considered separately. Such a high prevalence makes it the second most frequently occurring cancer, after breast cancer, and the second leading cause of death, after lung cancer.  In ideal situations, where the cancer is diagnosed in early stages, doctors can remove the tumor via surgical procedures. A colonoscopy is an important screening test for colorectal cancer, and it has become a part of routine cancer screening. The annual count of adults getting screened for cancer surged by 3.3 million in the US during 2014–2016, which is considered a prime factor associated with a 30% decrease in colon cancer mortality rate in people older than 50 in the past decade. In its updated screening guidelines released in 2018, the American Cancer Society quoted colonoscopies as the gold standard for detecting cancers and precancerous polyps in the colon. Also, to significantly reduce the adenoma “miss rate” of standard forward-viewing colonoscopy, manufacturers across globe are continuously striving to improve the current colonoscopy techniques, by exploring more advanced optics and wider-angle visualization tools along with a user-friendly, intuitive endoscopic platform interface. The introduction of such technologies is fuelling the colonoscope market growth.

The COVID-19 pandemic has severely impacted medical care in South and Central America. Market participants and end users are losing their businesses due to the temporary closure of companies in different countries. In this situation, there was the discontinuation of diagnosis and other related treatments. However, the COVID-19 outbreak has had a negative impact on the flow of medical care in the area. The COVID-19 pandemic has shifted the accepted and routine treatment of elective cases in hospital administration. This postponement resulted in a delay in the treatment of all non-COVID-19 patients, including cancer patients. The pandemic can lead to further potential innovations in cancer screening. Colon cancer screening programs (CRC) have been forcibly suspended since the pandemic began. A hospital system in distress needs a systematic approach to ensure timely cancer care. Screening delays beyond 4–6 months would significantly increase advanced CRC cases and mortality if they lasted longer than 12 months.

 colonoscopes market
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

SOUTH AND CENTRAL AMERICA COLONOSCOPES MARKET SEGMENTATION

By Product Type

  • Fiber Optic Colonoscopy Devices
  • Video Colonoscopy Devices

By Application

  • Colorectal Cancer
  • Lynch Syndrome
  • Ulcerative Colitis
  • Crohn's Disease
  • Polyp

By End User

  • Hospitals
  • Ambulatory Surgery Center
  • Other End Users

By Country

  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

  • Fujifilm Corporation
  • Olympus Corporation
  • KARL STORZ SE & Co. KG
  • PENTAX Medical
  • Boston Scientific Corporation
  • SonoScape Medical Corp.

South and Central America Colonoscopes Report Scope

Report Attribute Details
Market size in 2021 US$ 136.89 Million
Market Size by 2028 US$ 169.50 Million
Global CAGR (2021 - 2028) 3.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product Type
  • Fiber Optic Colonoscopy Devices and Video Colonoscopy Devices
By Application
  • Colorectal Cancer
  • Lynch Syndrome
  • Ulcerative Colitis
  • Crohn's Disease
  • Polyp
By End User
  • Hospitals
  • Ambulatory Surgery Center
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Fujifilm Corporation
  • Olympus Corporation
  • KARL STORZ SE & Co. KG
  • PENTAX Medical
  • Boston Scientific Corporation
  • SonoScape Medical Corp.
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
ISO Certified Logo